Roche To Launch Short Duration Infusion Gazyvaro For Patient

SOUTH SAN FRANCISCO (dpa-AFX) - Roche (RHHBY) reported EMA approval of a shorter 90-minute Gazyvaro infusion time, administered in combination with chemotherapy in patients with previously treated

Related Keywords

Levi Garraway , , Chief Medical Officer , Roche , Launch , Short , Uration , Infusion , Azyvaro , Patients ,